The development of tolerance to nicotine parallels, and may be causally linked to the development of dependent smoking behavior. Understandably, considerable attention has been given to identifying the mechanisms underlying tolerance. Research has focused on kinetic changes in drug distribution, or on cellular nervous system changes in receptor sensitivity. However, we have demonstrated a third factor, namely, that learned associations with environmental cues predicting nicotine delivery can powerfully contribute to the tolerance process. Thus tolerance to intermittent nicotine exposure can include """"""""associative"""""""" (learned) and """"""""nonassociative"""""""" components, and both must be considered if the tolerance process, and its contribution to smoking behavior, are to be thoroughly understood. Our current research is designed to better identify the mechanisms of conditioned tolerance. Using nicotine-induced antinociception and activation of the hypothalamic-pituitary-adrenocortical system (HPA) in laboratory rats as models, we propose to more systematically investigate the mechanisms of conditioned tolerance. Our strategy in Experiments 1-4 will be to first clarify the levels of the nervous system where nicotine acts acutely to produce its effects. This will be accomplished by combining central- vs peripheral-nervous system stimulation of nicotinic-cholinergic systems with selective central vs peripheral pharmacological blockade to better identify where nicotine is acting to produced its antinociceptive and HPA effects. Exploiting the results and methods of Experiment 1-4 on the location of nicotine's action and using an established paradigm for distinguishing associative from nonassociative tolerance, we will continue to ask -- in the remaining studies of this proposal -- the fundamental questions of this research program: what is being conditionally released to reduce nicotine responsiveness and where is it acting?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA007546-05
Application #
2608196
Study Section
Human Development Research Subcommittee (NIDA)
Project Start
1992-07-01
Project End
1999-11-30
Budget Start
1997-12-15
Budget End
1998-11-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Donny, E C; Caggiula, A R; Rose, C et al. (2000) Differential effects of response-contingent and response-independent nicotine in rats. Eur J Pharmacol 402:231-40
McCallum, S E; Caggiula, A R; Booth, S et al. (2000) Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats. Psychopharmacology (Berl) 150:8-Jan
McAllister-Sistilli, C G; Caggiula, A R; Knopf, S et al. (1998) The effects of nicotine on the immune system. Psychoneuroendocrinology 23:175-87
Caggiula, A R; Donny, E C; Epstein, L H et al. (1998) The role of corticosteroids in nicotine's physiological and behavioral effects. Psychoneuroendocrinology 23:143-59
Caggiula, A R; Antelman, S M; Kucinski, B J et al. (1998) Oscillatory-sensitization model of repeated drug exposure: cocaine's effects on shock-induced hypoalgesia. Prog Neuropsychopharmacol Biol Psychiatry 22:511-21
Robinson-Vanderwerf, T M; Di Pirro, J M; Caggiula, A R et al. (1997) The analgesia-enhancing component of ingested amniotic fluid does not affect nicotine-induced antinociception in naltrexone-treated rats. Pharmacol Biochem Behav 58:147-51
Caggiula, A R; Antelman, S M; Palmer, A M et al. (1996) The effects of ethanol on striatal dopamine and frontal cortical D-[3H]aspartate efflux oscillate with repeated treatment. Relevance to individual differences in drug responsiveness. Neuropsychopharmacology 15:125-32
Antelman, S M; Caggiula, A R; Kiss, S et al. (1995) Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment: possibly a major factor in drug variability. Neuropsychopharmacology 12:297-306
Caggiula, A R; Epstein, L H; Perkins, K A et al. (1995) Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms. Psychopharmacology (Berl) 122:301-6
Donny, E C; Caggiula, A R; Knopf, S et al. (1995) Nicotine self-administration in rats. Psychopharmacology (Berl) 122:390-94

Showing the most recent 10 out of 11 publications